• 1
    RiesLAG, EisnerMP, KosaryCL, et al., editors. SEER cancer statistics review, 1973–1997. Bethesda: National Cancer Institute, 2000.
  • 2
    Blot WJ, Devesa SS, Kneller RW, Fraumeni JF, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J Am Med Assoc. 1991; 265: 12871289.
  • 3
    Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993; 104: 510513.
  • 4
    Spechler SJ. Esophageal columnar metaplasia (Barrett's esophagus). Gastrointest Endosc Clin North Am. 1997; 7: 118.
  • 5
    Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med. 1986; 315: 362371.
  • 6
    Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am. 1997; 26: 487494.
  • 7
    Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's esophagus): comparison of population-based clinical and autopsy findings. Gastroenterology. 1990; 99: 918922.
  • 8
    Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999; 340: 825831.
  • 9
    Weinstein WM. Precursor lesions for cancer of the cardia. Gastrointest Endosc Clin North Am. 1997; 7: 1928.
  • 10
    Provenzale D, Homan RK. Screening for Barrett's esophagus in patients with GERD: can we afford the cost? [abstract]. Am J Gastroenterol. 2001; 96: S278.
  • 11
    Provenzale D, Kemp JA, Arora S, Wong JB. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol. 1994; 89: 670680.
  • 12
    American Society for Gastrointestinal Endoscopy. The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract. Gastrointest Endosc. 1998; 48: 663668.
  • 13
    Streitz JM, Jr., Andrews CW, Jr., Ellis FH, Jr., Endoscopic surveillance of Barrett's esophagus: does it help? J Thorac Cardiovasc Surg. 1993; 105: 383388.
  • 14
    Roberston CS, Mayberry JF, Nicholson DA, James PD, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg. 1988; 75: 760763.
  • 15
    Altorki NK, Skinner DB. Adenocarcinoma in Barrett's esophagus. Semin Surg Oncol. 1990; 6: 274278.
  • 16
    Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993; 31: 732748.
  • 17
    Corley DA, Levin TR, Habel L, Weiss NS, Buffler P. Surveillance and survival in Barrett's adenocarcinoma: a population-based study. Gastroenterology. 2002; 122: 633640.
  • 18
    Kearney DJ, Crump C, Maynard C, Boyko E. A case-control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia for persons with chronic gastroesophageal reflux disease [abstract]. Gastroenterology. 2001; 120: A-414.
  • 19
    Catanzaro AT, Faulx AL, Pfau PR, et al. Accuracy of a narrow diameter battery powered endoscope in sedated and unsedated patients. Gastrointest Endosc. 2002; 55: 484487.
  • 20
    Faulx AL, Catanzaro AT, Zyzanski S, et al. Patient tolerance and acceptability of unsedated ultrathin esophagoscopy. Gastrointest Endosc. 2002; 55: 620623.
  • 21
    Canto MIF, Setrakian S, Petras RE, Blades E, Chak A, Sivak MV Jr. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc. 1996; 44: 17.
  • 22
    Falk GW, Chittajallu R, Goldblum JR, et al. Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology. Gastroenterology. 1997; 112: 17871797.
  • 23
    Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology. 1992; 102: 12121219.
  • 24
    Sharma P, Weston A, Falk G, Johnston M, Reker D, Sampliner R. Can two upper endoscopies negative for dysplasia eliminate the need for future surveillance in patients with Barrett's esophagus [abstract]. Am J Gastroenterol. 2001; 96: S36.
  • 25
    Cooper GS, Yuan Z, Stange KC, Dennis LK, Amini SB, Rimm AA. The sensitivity of Medicare claims data for case ascertainment of six common cancers. Med Care. 1999; 37: 436444.
  • 26
    Javitt JC, McBean AM, Sastry SS, DiPaolo F, Jr. Accuracy of coding in Medicare Part B claims: cataract as a case study. Arch Ophthalmol. 1993; 111: 605607.
  • 27
    Fisher ES, Whaley FS, Krushat WM, et al. The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health. 1992; 82: 243248.
  • 28
    Romano PS, Luft HS. Getting the most out of messy data: problems and approaches for dealing with large administrative data sets. In: GradyML, SchwartzHA. Medical effectiveness research data methods. Rockville, MD: U.S. Public Health Service, 1992.
  • 29
    Cooper GS, Chak A, Lloyd LE, Hammar PJ, Harper DL, Rosenthal GE. The accuracy of diagnosis and procedural codes for patients with upper gastrointestinal hemorrhage. Gastrointest Endosc. 2000; 51: 423426.
  • 30
    Cooper GS, Yuan Z, Stange KC, Dennis LK, Amini SB, Rimm AA. Agreement of Medicare claims and tumor registry data for assessment of cancer related treatment. Med Care. 2000; 38: 411421.
  • 31
    Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine (2nd edition). Boston: Little Brown, 1991.